Skip to main content
OpenTrials
Completed

NCT Number: NCT00613405

Stress and Marijuana Cue-elicited Craving and Reactivity

The purpose of this study is to explore the interaction between stress and marijuana cues, in hopes that it may lead to the development of new treatments for marijuana dependence.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Medical University of South Carolina

Charleston, South Carolina, 29425, United States

About this study

Although use of marijuana is widespread, little research has focused on the treatment of marijuana use disorders or on predictors of relapse. Although several factors contributing to relapse have been explored in other dependencies (i.e., alcohol, cocaine), little research has focused on drug cue-related or stress-induced relapse in marijuana-dependent individuals. Cue reactivity is a construct measured in a laboratory procedure where an individual's subjective, behavioral, and physiological responses are assessed following exposure to drug-related environmental cues or stressors. Investigating the effects of drug-related environmental cues and stress in marijuana-dependent individuals will be useful in guiding treatment development.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Meets Diagnostic and Statistical Methods (DSM)-IV Criteria for Marijuana Dependence
  • Between the ages of 18 and 65
  • Must abstain from marijuana use the day of testing and other drug use three days prior to testing

Exclusion criteria

  • Must not be taking any psychoactive medication, or medication that alters the hypothalamic pituitary adrenal (HPA) Axis functioning
  • Must not be taking any medications that alter heart rate or skin conductance monitoring
  • Cannot meet criteria for current major Axis I disorder (may alter response to stress)
  • Cannot be morbidly obese (Body Mass Index >39)
  • Cannot meet current abuse or dependence criteria of other substances in past 90 days
  • Must not have a medical condition that impacts HPA functioning (Hypertension, chronic pain, Addison's disease)

Treatment and study plan

Stress + cue exposure

Other

Trier Social Stress Task(TSST): subject is asked to give a talk and perform a math task in front of an audience, follwed by neutral and marijuana cue exposure.

Other names: Stress stask, TSST

No stress + cue exposure

Other

Neutral and marijuana-associated cue exposure (scripted imagery, in vivo cues).

Other names: marijuana cue exposure, neutral cue exposure

Primary outcomes

  1. Subjective Craving of Marijuana

    Time frame: approx 2.5 hours (before, during and after exposure to stressor condition as well as exposure to neutral and marijuana-associated cues).

    Defined as the score on the Marijuana Craving Questionnaire (MCQ), range 7-84, higher scores indicate more craving

Secondary outcomes

  1. Physiological Assessments: Serum Cortisol, ACTH, BP, HR, and GSR

    Time frame: ~ 2.5 hours (before, during and after exposure to stressor condition as well as exposure to neutral and marijuana-associated cues).

  2. Feelings of Stress/Anxiety as Measured by the State-Trait Inventory (STAI)

    Time frame: ~2 hours

  3. Current Mood as Assessed by the Mood Form

    Time frame: ~2 hours

Sponsors and collaborators

Lead sponsor

Medical University of South Carolina

Other

Collaborators

  • National Institute on Drug Abuse (NIDA)

Registry information

Important dates

Study start
2008
Primary completion
2009
Study completion
2009
First posted
Feb 13, 2008
Registry last updated
Apr 30, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.